title: The early course of newly diagnosed asthma.
abstract: OBJECTIVE
  We describe the intensity of therapy for patients with newly diagnosed asthma and how it changed during subsequent years in relation to age, sex, and initial level of therapy.
  
  
  METHODS
  We examined a cohort of 13,671 patients in Saskatchewan, Canada, who were initially between the ages of 5 and 44 years. Patients were followed prospectively, and the intensity of asthma therapy was measured during successive 12-month periods.
  
  
  RESULTS
  Based on the intensity of asthma drug therapy during the first year after entry into the cohort, 6661 patients (48.7%) were initially prescribed therapy judged to be appropriate for mild asthma, and 977 (7.1%) were dispensed medications in a manner suggesting their asthma was severe; the remaining 6033 (44.1%) were classified as receiving treatment of intermediate intensity. Among patients initially classified as receiving treatment appropriate for mild disease, only about 3% were dispensed medications that suggested that their asthma had become severe during up to 5 years of follow-up. Intensity of therapy waned in a substantial proportion of patients who were initially classified as having severe asthma, especially if they were initially younger than 15 years of age. Thirty-four per 100 patients initially younger than 15 years old were receiving medications appropriate for mild asthma, and 23 per 100 such patients received no medication for asthma during a 12-month period when followed up to 5 years.
  
  
  CONCLUSIONS
  Patients with asthma who are initially treated with therapy appropriate for mild asthma are rarely treated later with therapy suggesting the advent of severe disease. Patients initially dispensed medications suggesting the presence of severe asthma often see the intensity of treatment wane over time.
authors.affiliation: Division of Clinical Epidemiology, Royal Victoria Hospital, and Pharmacoepidemiology Research Unit, McGill University Health Center, Montreal, Québec, Canada.
authors.forename: Pierre
authors.initials: P
authors.lastname: Ernst
authors.forename: Bing
authors.initials: B
authors.lastname: Cai
authors.forename: Lucie
authors.initials: L
authors.lastname: Blais
authors.forename: Samy
authors.initials: S
authors.lastname: Suissa
mesh_terms: D000293:Adolescent; D000328:Adult; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology*; D002648:Child; D002675:Child, Preschool; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male
chemical_list: D018927:Anti-Asthmatic Agents